Search
for
Sort by
Research 211–240 of 584
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Real-world evidence in alopecia areata treatment: A narrative review
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Immune therapies for alopecia areata: evidence and new perspectives
- mTOR signaling in hair follicle and hair diseases: recent progress
- Skin Pigmentation Types, Causes and Treatment—A Review
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Interleukin-6 Null Mice Paradoxically Display Increased STAT3 Activity and Wound-Induced Hair Neogenesis
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Alopecia Areata: An Updated Review for 2023
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- New and Emerging Therapies for Alopecia Areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Treating Alopecia Areata: Current Practices Versus New Directions
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Alopecia areata – Current understanding and management
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Alopecia areata – Aktuelles Verständnis und Management
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Baricitinib: A Review in Severe Alopecia Areata
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- New Modalities in the Treatment of Refractory Alopecia Areata